Synlett 1991; 1991(12): 873-875
DOI: 10.1055/s-1991-20908
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Preparation of Novel C-25 Alkenylavermectin Derivatives

B. J. Banks* , B. R. Fenner, V. F. Voss, M. J. Witty
  • *Animal Health Discovery Research, Pfizer Central Research, Ramsgate Road, Sandwich, Kent CT13 9NJ, England
Further Information

Publication History

Publication Date:
07 March 2002 (online)

The pyrolysis of 25-(1-methylsulphinylalkyl)avermectins provides, in good yield, novel avermectins with C-25 substituents containing terminal alkenyl groups. The use of palladium(II) acetate catalyst permits the highly selective elaboration of such compounds to more complex C-25 alkenes and their derivatives, without the use of protecting groups and in the presence of acid- and base-labile functionalities.

    >